Announcement:

Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma

New Blog Post:

First-in-Human Results for GB-0669: Durable Neutralization from an AI-Designed Antibody

Ross Federman

Name: Generate:Biomedicines
Price range: $

Scientist II

Now we can.

Generate:Biomedicines

101 South Street, Suite 900
Somerville, MA 02143

United States